AIM
ALNY icon

Assured Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Assured Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,826
Closed -$232K – 1159
2017
Q4 		$232K Buy
+1,826
New +$229K ﹤0.01% 489
2016
Q3 		– Sell
-9,608
Closed -$533K – 601
2016
Q2 		$533K Buy
9,608
+6,429
+202% +$405K 0.01% 397
2016
Q1 		$200K Buy
3,179
+1,500
+89% +$99.7K ﹤0.01% 486
2015
Q4 		$158K Sell
1,679
-3
-0.2% -$278 ﹤0.01% 498
2015
Q3 		$135K Buy
1,682
+267
+19% +$29.7K ﹤0.01% 533
2015
Q2 		$170K Buy
+1,415
New +$169K ﹤0.01% 512

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Assured Investment Management's ALNY Position: Q1 2018 in Review

Assured Investment Management sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2018, closing a stake of 1,826 shares — an estimated $232K sold.

Assured Investment Management first reported a position in ALNY in Q2 2015 and held it in 6 quarters. The position peaked at $533K in Q2 2016. 293 funds tracked by Wall St. Rank hold ALNY as of Q1 2018.

  • Assured Investment Management reported no remaining Alnylam Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Assured Investment Management sold 1,826 Alnylam Pharmaceuticals shares in Q1 2018, an estimated $232K.
  • Assured Investment Management first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 6 quarters.
  • Assured Investment Management's Alnylam Pharmaceuticals position peaked at $533K in Q2 2016.
  • 293 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2018.

Based on Assured Investment Management's 13F filing for Q1 2018, filed 14 May 2018.